This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (42)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PAUL STARR, M.D.

AMA Arch Intern Med. 1958;101(4):722-730.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The clinical and physiological comparisons of the isomers of thyroxine by a number of investigators are well summarized by Tabachnik et al. in a recent publication.¹ Some excellent animal measurements of oxygen consumption suggest complete lack of potency of the dextro- isomer,² whereas other studies,³ with use of a different phenomenon, demonstrate physiological activity. Most of these studies were done with racemic mixtures of the two isomers, as compared with the results of the administration of the levo- isomer alone. A generous provision of unlimited quantities of sodium D-thyroxine, suitable for clinical studies, has permitted an extended series of human observations.* Amounts of the sodium D-thyroxine sufficient to administer 100 times the usual levo- isomer dosage have made possible hitherto unavailable comparisons. The present studies, however, were done at the dose levels regularly used clinically in the treatment of hypothyroidism with L-thyroxine.

The chemical characteristics of the . . . [Full Text PDF of this Article]

Author Affiliations
Los Angeles

From the School of Medicine, Department of Medicine, the University of Southern California, and the Thyroid Clinic, Los Angeles County Hospital.

Footnotes
Submitted for publication July 15, 1957.

Supported by Baxter Laboratories, Inc., Morton Grove, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?